These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 25873087)

  • 1. Analyses of 7,635 Patients with Colorectal Cancer Using Independent Training and Validation Cohorts Show That rs9929218 in CDH1 Is a Prognostic Marker of Survival.
    Smith CG; Fisher D; Harris R; Maughan TS; Phipps AI; Richman S; Seymour M; Tomlinson I; Rosmarin D; Kerr D; Chan AT; Peters U; Newcomb PA; Idziaszczyk S; West H; Meade A; Kaplan R; Cheadle JP
    Clin Cancer Res; 2015 Aug; 21(15):3453-61. PubMed ID: 25873087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of colorectal cancer-risk loci and survival outcome: A prognostic role for CDH1 variants.
    Summers MG; Maughan TS; Kaplan R; Law PJ; Houlston RS; Escott-Price V; Cheadle JP
    Eur J Cancer; 2020 Jan; 124():56-63. PubMed ID: 31734605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDH1 rs9929218 variant at 16q22.1 contributes to colorectal cancer susceptibility.
    Han P; Liu G; Lu X; Cao M; Yan Y; Zou J; Li X; Wang G
    Oncotarget; 2016 Jul; 7(30):47278-47286. PubMed ID: 27259261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation rs9929218 and risk of the colorectal Cancer and adenomas: A meta-analysis.
    Wang H; Gu D; Yu M; Hu Y; Chen Z; Huo X; Yu T; Chen J; Zheng Y
    BMC Cancer; 2021 Feb; 21(1):190. PubMed ID: 33627078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer susceptibility loci and influence on survival.
    Song N; Kim K; Shin A; Park JW; Chang HJ; Shi J; Cai Q; Kim DY; Zheng W; Oh JH
    Genes Chromosomes Cancer; 2018 Dec; 57(12):630-637. PubMed ID: 30350386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide association study identifies tumor anatomical site-specific risk variants for colorectal cancer survival.
    Labadie JD; Savas S; Harrison TA; Banbury B; Huang Y; Buchanan DD; Campbell PT; Gallinger SJ; Giles GG; Gunter MJ; Hoffmeister M; Hsu L; Jenkins MA; Lin Y; Ogino S; Phipps AI; Slattery ML; Steinfelder RS; Sun W; Van Guelpen B; Hua X; Figuieredo JC; Pai RK; Nassir R; Qi L; Chan AT; Peters U; Newcomb PA
    Sci Rep; 2022 Jan; 12(1):127. PubMed ID: 34996992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic susceptibility variants associated with colorectal cancer prognosis.
    Abulí A; Lozano JJ; Rodríguez-Soler M; Jover R; Bessa X; Muñoz J; Esteban-Jurado C; Fernández-Rozadilla C; Carracedo A; Ruiz-Ponte C; Cubiella J; Balaguer F; Bujanda L; Reñé JM; Clofent J; Morillas JD; Nicolás-Pérez D; Xicola RM; Llor X; Piqué JM; Andreu M; Castells A; Castellví-Bel S;
    Carcinogenesis; 2013 Oct; 34(10):2286-91. PubMed ID: 23712746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between GWAS-identified genetic variations and disease prognosis for patients with colorectal cancer.
    Kang BW; Jeon HS; Chae YS; Lee SJ; Park JY; Choi JE; Park JS; Choi GS; Kim JG
    PLoS One; 2015; 10(3):e0119649. PubMed ID: 25799222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide Discovery and Identification of a Novel miRNA Signature for Recurrence Prediction in Stage II and III Colorectal Cancer.
    Kandimalla R; Gao F; Matsuyama T; Ishikawa T; Uetake H; Takahashi N; Yamada Y; Becerra C; Kopetz S; Wang X; Goel A
    Clin Cancer Res; 2018 Aug; 24(16):3867-3877. PubMed ID: 29514841
    [No Abstract]   [Full Text] [Related]  

  • 10. ADH1B and CDH1 polymorphisms predict prognosis in male patients with non-metastatic laryngeal cancer.
    Li D; Zhang R; Jin T; He N; Ren L; Zhang Z; Zhang Q; Xu R; Tao H; Zeng G; Gao J
    Oncotarget; 2016 Nov; 7(45):73216-73228. PubMed ID: 27689323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of cyclin D1 (CCND1) and E-cadherin (CDH1) alterations to colorectal cancer susceptibility: a case-control study.
    Govatati S; Singamsetty GK; Nallabelli N; Malempati S; Rao PS; Madamchetty VK; Govatati S; Kanapuram R; Narayana N; Bhanoori M; Kassetty K; Nallanchakravarthula V
    Tumour Biol; 2014 Dec; 35(12):12059-67. PubMed ID: 25146682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility genetic variants associated with colorectal cancer risk correlate with cancer phenotype.
    Abulí A; Bessa X; González JR; Ruiz-Ponte C; Cáceres A; Muñoz J; Gonzalo V; Balaguer F; Fernández-Rozadilla C; González D; de Castro L; Clofent J; Bujanda L; Cubiella J; Reñé JM; Morillas JD; Lanas A; Rigau J; García AM; Latorre M; Saló J; Fernández Bañares F; Argüello L; Peña E; Vilella A; Riestra S; Carreño R; Paya A; Alenda C; Xicola RM; Doyle BJ; Jover R; Llor X; Carracedo A; Castells A; Castellví-Bel S; Andreu M;
    Gastroenterology; 2010 Sep; 139(3):788-96, 796.e1-6. PubMed ID: 20638935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Prognostic and Predictive Value of Soluble Type IV Collagen in Colorectal Cancer: A Retrospective Multicenter Study.
    Rolff HC; Christensen IJ; Vainer B; Svendsen LB; Eefsen RL; Wilhelmsen M; Lund IK; Høyer-Hansen G; Nielsen HJ; Illemann M;
    Clin Cancer Res; 2016 May; 22(10):2427-34. PubMed ID: 26673797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of clinicopathological features with E-cadherin (CDH1) gene-160 C>A promoter polymorphism in Turkish colorectal cancer patients.
    Bahadir A; Eral G; Budak M; Shimamoto F; Korpinar MA; Erdamar S; Tuncel H
    J Cancer Res Ther; 2019; 15(1):26-31. PubMed ID: 30880750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twist2 is a valuable prognostic biomarker for colorectal cancer.
    Yu H; Jin GZ; Liu K; Dong H; Yu H; Duan JC; Li Z; Dong W; Cong WM; Yang JH
    World J Gastroenterol; 2013 Apr; 19(15):2404-11. PubMed ID: 23613636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A genome-wide search for determinants of survival in 1926 patients with advanced colorectal cancer with follow-up in over 22,000 patients.
    Wills C; He Y; Summers MG; Lin Y; Phipps AI; Watts K; Law PJ; Al-Tassan NA; Maughan TS; Kaplan R; Houlston RS; Peters U; Newcomb PA; Chan AT; Buchanan DD; Gallinger S; Marchand LL; Pai RK; Shi Q; Alberts SR; Gray V; West HD; Escott-Price V; Dunlop MG; Cheadle JP
    Eur J Cancer; 2021 Dec; 159():247-258. PubMed ID: 34794066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CDH1-160C>A polymorphism is a risk factor for colorectal cancer.
    Pittman AM; Twiss P; Broderick P; Lubbe S; Chandler I; Penegar S; Houlston RS
    Int J Cancer; 2009 Oct; 125(7):1622-5. PubMed ID: 19569232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short article: Influence of regulatory NLRC5 variants on colorectal cancer survival and 5-fluorouracil-based chemotherapy.
    Catalano C; da Silva Filho MI; Jiraskova K; Vymetalkova V; Levy M; Liska V; Vycital O; Naccarati A; Vodickova L; Hemminki K; Vodicka P; Weber ANR; Försti A
    Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):838-842. PubMed ID: 29762254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A let-7 microRNA SNP in the KRAS 3'UTR is prognostic in early-stage colorectal cancer.
    Smits KM; Paranjape T; Nallur S; Wouters KA; Weijenberg MP; Schouten LJ; van den Brandt PA; Bosman FT; Weidhaas JB; van Engeland M
    Clin Cancer Res; 2011 Dec; 17(24):7723-31. PubMed ID: 21994416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional polymorphisms of ATP citrate lyase gene predicts clinical outcome of patients with advanced colorectal cancer.
    Xie S; Zhou F; Wang J; Cao H; Chen Y; Liu X; Zhang Z; Dai J; He X
    World J Surg Oncol; 2015 Feb; 13():42. PubMed ID: 25890184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.